Cellromax Science Co

Cellromax Science Co Total Assets

The Total Assets of Cellromax Science Co (471820.KQ) as of Nov 5, 2026 is 50.91 B KRW. In the previous year, Total Assets was 49.10 B KRW — a change of 3.68% (higher).

Total Assets

50.91 BKRW

YoY

3.68%

Last updated:

Total Assets of Cellromax Science Co is 2025 50.91 B KRW. Total Assets of Cellromax Science Co was 2024 49.10 B KRW. It decreases by 3.68% higher compared to the previous year.

The Cellromax Science Co Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2022
28.53 B KRW
Jan 1, 2023
32.83 B KRW
Jan 1, 2024
49.10 B KRW
Jan 1, 2025
50.91 B KRW
The Cellromax Science Co Total Assets history
YEARTotal AssetsYoY
50.91 BKRW+3.68%
49.10 BKRW+49.57%
32.83 BKRW+15.06%
28.53 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cellromax Science Co Stock analysis

What does Cellromax Science Co do? Cellromax Science Co Ltd generates revenue through the development and distribution of health functional foods, functional cosmetics, and general medicines. The company's primary brand, 'Cellromax,' targets consumers seeking health and wellness solutions. Its products are sold to customers interested in health-focused lifestyle choices, including those purchasing functional foods and cosmetics for daily use. The firm operates within the health and wellness sector, focusing on product innovation and consumer demand for natural health solutions. The company's business model centers around its brand 'Cellromax,' which is used across its health functional food and cosmetic product lines. Revenue is derived from direct sales of these branded products to end consumers. The firm's focus on functional foods and cosmetics positions it within the health and wellness market segment, catering to individuals prioritizing health maintenance and beauty enhancement through scientifically backed products. Cellromax Science Co Ltd's product portfolio includes health functional foods, functional cosmetics, and general medicines. The company distributes these items through retail channels to consumers seeking health and beauty solutions. Its brands, particularly 'Cellromax,' drive customer engagement and sales, with the company emphasizing product quality and scientific validation to attract health-conscious buyers in the Korean market. Cellromax Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellromax Science Co stock

Total Assets of Cellromax Science Co is 50.91 B KRW in 2025.

Total Assets of Cellromax Science Co changed from 49.10 B KRW to 50.91 B KRW, representing a 3.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Cellromax Science Co since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Cellromax Science Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cellromax Science Co

All Key Metrics — Cellromax Science Co